#AJKDBlog
LightNews LightNews
ajkd.bsky.social
Hope you like the #NephMadness 2027 logo!

bit.ly/NM27Logo

If you're at #KidneyWk, pick up a logo magnet at the NKF booth 302.

Special thanks to Graham Gipson for designing the logo.
#NephMadness 2027: Logo Reveal
It’s Kidney Week 2026! As many of you gather in Denver, we at the AJKDblog observe a tradition as old as time (or at least 2018); unveiling the logo for #NephMadness 2027. Our thanks as alway…
bit.ly
October 23, 2026 at 12:37 PM
ajkd.bsky.social
#AJKDBlog Commentary: Sustainable Kidney Care: Aligning Patient and Planetary Health

bit.ly/4kEIjUz
October 20, 2026 at 4:03 PM
ajkd.bsky.social
NEW Commentary by Dr. Nicole Wyatt on #AJKDBlog:

Creatinine vs Cystatin C: A Tale of Two Filtration Markers

bit.ly/4835Usw
October 19, 2026 at 10:01 PM
ajkd.bsky.social
Commentary by Natasha Freeman on the #AJKDBlog:

A Call for Better Cancer Screening Guidelines for Patients with Glomerular Disease

bit.ly/4A5ziLx
October 8, 2026 at 4:02 PM
ajkd.bsky.social
On the #AJKDBlog:

@maximalchange.bsky.social interviews Niraj B. Desai, Casey Gashti, and @nephrowhitt.bsky.social about the history of lupus nephritis and several exciting new therapies:
Lupus Nephritis, “A Change Is Gonna Come”: An Interview
Systemic lupus erythematosus (SLE) is a chronic, multiorgan autoimmune disease, with lupus nephritis (LN) affecting up to 60% of patients. Early diagnosis and treatment are critical for preserving …
bit.ly
October 4, 2026 at 10:00 PM
ajkd.bsky.social
NEW Blog Interview from Timothy Yau and Ikechi G. Okpechi on the #AJKDBlog:

Chronic Kidney Disease Prevalence in Africa

bit.ly/4xQzuvP (FREE)
October 2, 2026 at 10:00 PM
ajkd.bsky.social
NEW Blog Commentary from AJKD Editorial Intern Dr. Elias John Elenjickal on the #AJKDBlog:

Rethinking Osteoporosis Therapy in Chronic Kidney Disease

bit.ly/4dPHXbp (FREE)
September 28, 2026 at 10:01 PM
ajkd.bsky.social
NEW Blog Commentary from AJKD Editorial Intern Dr. Elias John Elenjickal on the #AJKDBlog:

Rethinking Osteoporosis Therapy in Chronic Kidney Disease

bit.ly/4dPHXbp (FREE)
September 24, 2026 at 5:00 PM
ajkd.bsky.social
NEW on the #AJKDBlog:

@maximalchange.bsky.social interviews Christopher Blosser & Naoka Murakami on Malignancy in Kidney Transplant Recipients bit.ly/4xGfFHO

Read their Core Curriculum: bit.ly/42Z2cxG (FREE)
Malignancy in Kidney Transplant Recipients: An Interview
Kidney transplant recipients are at least twice as likely to develop cancer compared with immunocompetent people. Cancer is now the second leading cause of death in kidney transplant recipients. In…
bit.ly
September 21, 2026 at 10:00 AM
ajkd.bsky.social
⚡️AJKD Express is an expedited consideration process for full-length original research articles: Authors of eligible #AJKDExpress articles will be notified of decision within 7-16 business days.⚡️

Details on #AJKDBlog: bit.ly/2Ws8rtp
September 20, 2026 at 10:00 AM
ajkd.bsky.social
NEW on the #AJKDBlog:

@maximalchange.bsky.social interviews Christopher Blosser & Naoka Murakami on Malignancy in Kidney Transplant Recipients bit.ly/4xGfFHO

Read their Core Curriculum: bit.ly/42Z2cxG (FREE)
Malignancy in Kidney Transplant Recipients: An Interview
Kidney transplant recipients are at least twice as likely to develop cancer compared with immunocompetent people. Cancer is now the second leading cause of death in kidney transplant recipients. In…
bit.ly
September 19, 2026 at 4:00 PM
ajkd.bsky.social
NEW on the #AJKDBlog:

@maximalchange.bsky.social interviews Christopher Blosser & Naoka Murakami on Malignancy in Kidney Transplant Recipients bit.ly/4xGfFHO

Read their Core Curriculum: bit.ly/42Z2cxG (FREE)
Malignancy in Kidney Transplant Recipients: An Interview
Kidney transplant recipients are at least twice as likely to develop cancer compared with immunocompetent people. Cancer is now the second leading cause of death in kidney transplant recipients. In…
bit.ly
September 17, 2026 at 2:01 PM
ajkd.bsky.social
NEW Commentary by Natasha Freeman on the #AJKDBlog:

A Call for Better Cancer Screening Guidelines for Patients with Glomerular Disease

bit.ly/4A5ziLx
September 14, 2026 at 10:00 PM
ajkd.bsky.social
NEW Commentary by Natasha Freeman on the #AJKDBlog:

A Call for Better Cancer Screening Guidelines for Patients with Glomerular Disease

bit.ly/4A5ziLx
September 12, 2026 at 4:00 PM
ajkd.bsky.social
NEW Commentary by Natasha Freeman on the #AJKDBlog:

A Call for Better Cancer Screening Guidelines for Patients with Glomerular Disease

bit.ly/4A5ziLx
September 10, 2026 at 10:00 AM
ajkd.bsky.social
NEW on the #AJKDBlog:

@maximalchange.bsky.social interviews David Leehey on pentoxifylline for diabetic kidney disease:

bit.ly/4xZUkJK
Pentoxifylline for Diabetic Kidney Disease: An Interview
For many years, the only specific pharmacologic intervention to decrease end-stage kidney disease in diabetic kidney disease was renin-angiotensin-aldosterone system blockade. Despite the addition …
bit.ly
September 1, 2026 at 10:00 PM
ajkd.bsky.social
NEW on the #AJKDBlog:

@maximalchange.bsky.social interviews David Leehey on pentoxifylline for diabetic kidney disease:

bit.ly/4xZUkJK
Pentoxifylline for Diabetic Kidney Disease: An Interview
For many years, the only specific pharmacologic intervention to decrease end-stage kidney disease in diabetic kidney disease was renin-angiotensin-aldosterone system blockade. Despite the addition …
bit.ly
August 29, 2026 at 4:01 PM
ajkd.bsky.social
NEW Commentary by Ifeoluwa Stowe on the #AJKDBlog:

When Am I Comfortable with Acute Kidney Injury in Patients with Heart Failure Exacerbation?

bit.ly/4wISdsX
When Am I Comfortable with Acute Kidney Injury in Patients with Heart Failure Exacerbation?
Dr. Ifeoluwa Stowe is a nephrology fellow at Beth Israel Deaconess Medical Center/Harvard Medical School. She was born and raised in Nigeria where she completed medical school at the University of …
bit.ly
August 28, 2026 at 10:01 PM
ajkd.bsky.social
NEW on the #AJKDBlog:

@maximalchange.bsky.social interviews David Leehey on pentoxifylline for diabetic kidney disease:

bit.ly/4xZUkJK
Pentoxifylline for Diabetic Kidney Disease: An Interview
For many years, the only specific pharmacologic intervention to decrease end-stage kidney disease in diabetic kidney disease was renin-angiotensin-aldosterone system blockade. Despite the addition …
bit.ly
August 27, 2026 at 2:24 PM
ajkd.bsky.social
NEW Commentary by Ifeoluwa Stowe on the #AJKDBlog:

When Am I Comfortable with Acute Kidney Injury in Patients with Heart Failure Exacerbation?

bit.ly/4wISdsX
When Am I Comfortable with Acute Kidney Injury in Patients with Heart Failure Exacerbation?
Dr. Ifeoluwa Stowe is a nephrology fellow at Beth Israel Deaconess Medical Center/Harvard Medical School. She was born and raised in Nigeria where she completed medical school at the University of …
bit.ly
August 20, 2026 at 1:11 PM
ajkd.bsky.social
NEW on the #AJKDBlog:

@maximalchange.bsky.social interviews Meri Varkila on trends in US dialysis facility closures in the last decare and associated facility- and neighborhood-level characteristics bit.ly/3UdQM81
Dialysis Facility Closure Trends Over the Past Decade: An Interview
Between 2006 and 2016, the number of US dialysis facilities experienced steady annual growth. Recent data suggest a reversal in this trend. Varkila et al examined trends in US dialysis facility clo…
bit.ly
August 18, 2026 at 10:00 PM
ajkd.bsky.social
NEW on the #AJKDBlog:

@maximalchange.bsky.social interviews Meri Varkila on trends in US dialysis facility closures in the last decare and associated facility- and neighborhood-level characteristics bit.ly/3UdQM81
Dialysis Facility Closure Trends Over the Past Decade: An Interview
Between 2006 and 2016, the number of US dialysis facilities experienced steady annual growth. Recent data suggest a reversal in this trend. Varkila et al examined trends in US dialysis facility clo…
bit.ly
August 15, 2026 at 4:01 PM
ajkd.bsky.social
NEW Commentary by Zohreh Gholizadeh Ghozloujeh & @SaynaNorouzi on the #AJKDBlog:

After Remission, What Next? Rethinking Rituximab Strategy in Idiopathic Nephrotic Syndrome

bit.ly/4hqwpOL
After Remission, What Next? Rethinking Rituximab Strategy in Idiopathic Nephrotic Syndrome
Zohreh Gholizadeh Ghozloujeh, MD, is a research postdoctoral fellow in the Division of Nephrology at Loma Linda University School of Medicine. Her work focuses on rare kidney diseases, clinical res…
bit.ly
August 14, 2026 at 4:01 PM
hofstrakidney.bsky.social
@hiteshhshah on @ajkdblog on Sevelamer to help proteinuria in CKD https://ajkdblog.org/2019/09/16/can-sevelamer-reduce-proteinuria-in-patients-with-ckd-do-we-have-an-answer/
Can Sevelamer Reduce Proteinuria in Patients With CKD? Do...
In the United States, approximately 37 million people in ...
ajkdblog.org
December 9, 2024 at 12:51 PM
Which left a clear winner (and one that we picked as overall winner for #NephMadness 2019): new school volume assessment.
Read more about the region here:
https://ajkdblog.org/tag/nm19volume/
NM19Volume – AJKD Blog
Posts about NM19Volume written by AJKDblog
ajkdblog.org
November 23, 2024 at 12:07 AM